Lanean...
Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
OBJECTIVES: Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting antiviral agents (DAAs). METHODS: A retrospective study of patients receiv...
Gorde:
| Argitaratua izan da: | Eur J Hosp Pharm |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
European Journal of Hospital Pharmacy
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452397/ https://ncbi.nlm.nih.gov/pubmed/31157007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001277 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|